Investor Presentaiton

Cash flow DKKm EBIT 9M 2021/22 9M 2022/23 Change 4,661 5,126 10% Amortisation 174 245 41% Depreciation 497 547 10% Adjustment for other non-cash operating items 75 -166 nm Change in working capital -1,161 -1,314 13% Net interest payments Paid tax Cash flow from operations -202 -582 188% -1,085 -1,511 39% 2,959 2,345 -21% Investment in intangibles -114 -161 41% CAPEX¹ -609 -693 14% Acquisition of associates -2 nm Acquired operations - investments in other investments -10,633 -17 nm Securities 216 nm Cash flow from investments -11,358 -655 nm Free cash flow -8,399 1,690 nm Dividends -4,041 -4,247 5% Net aquisition of treasury shares and exercise of share options Repayment of lease liabilities -571 34 -106% -168 -180 7% Financing through issuing long-term bonds 16,367 nm Hedging gain 521 nm 1) Drawdown on credit facilities Net cash flow YTD 101 Net CAPEX including divestment of PPE and excluding finance leases -3,558 3,189 -190% 151 486 222% Coloplast

View entire presentation